Comparisons of Clinical Outcomes Between Novel Tailored Transvaginal Mesh Surgery and Vaginal Native Tissue Repair Surgery for Pelvic Organ Prolapse

Overview

The issue of whether utilizing the mesh in the surgical treatment of pelvic organ prolapse remained undetermined.Thus, the aim of this study is to analyze clinical outcome of women who underwent pelvic organ prolapse surgeries with and without mesh implantation in the Department of Obstetrics & Gynecology of National Taiwan University Hospital.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: April 2016

Detailed Description

Hypothesis / aims of study: The use of mesh for women with pelvic organ prolapsed (POP) remains under debate, despite a recent randomized trial reported a favourable anatomic outcome of transvaginal mesh (TVM) surgery for cystocele, compared with anterior colporrhaphy. Besides, the issue of preserving uterus or not in women with POP during operation is still undetermined. Thus, the aim of this study is to compare clinical outcomes of the novel tailored TVM surgeries and conventional transvaginal native tissue repair (NTR) surgeries for POP. Study design, materials and methods: Between November 2011 and September 2014, the medical records of all consecutive women who underwent POP surgeries in a medical centre were reviewed. The choice of surgery method was according to the surgeons' preference. Clinical characteristics and intraoperative data and postoperative clinical outcomes were recorded. Wilcoxon rank-sum test was used to compare the data between two groups. Kaplan-Meier survival analysis was used to compare the recurrence rate between two groups.

Interventions

  • Procedure: Pelvic organ prolapse surgery without mesh
    • retrospective study
  • Procedure: Pelvic organ prolapse surgery with mesh

Arms, Groups and Cohorts

  • pelvic organ prolapse
    • All women who underwent surgical treatment of pelvic organ prolapse in this study.

Clinical Trial Outcome Measures

Primary Measures

  • Recurrence rate of pelvic organ prolapse
    • Time Frame: 5 years
    • follow-up till postoperative 5 years

Participating in This Clinical Trial

Inclusion Criteria

  • All women who underwent surgical treatment of pelvic organ prolapse were enrolled in this study. – ≥ 20 years old female. Exclusion Criteria:

  • Healthy women – Without underwent surgical treatment of pelvic organ prolapse

Gender Eligibility: Female

Minimum Age: 20 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National Taiwan University Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Ho-Hsiung Lin, MD,PhD, 886-2-23123456, hhlin@ntuh.gov.tw

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.